Updated · AI-assisted evidence analysis
Super Snouts Joint Power Soft Chews Review 2026: What Does the Evidence Show?
Mussel joint research is mixed, and this chew has no amounts or trial — Overhyped
-
"Helps with joint discomfort or stiffness from normal activity"
Dogs with diagnosed arthritis improved more on green-lipped mussel than placebo in some trials. Those were arthritic dogs, not dogs with everyday stiffness, and they used other mussel products. The page prints no amounts to compare.
Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus). → · Clinical efficacy and tolerance of an extract of green-lipped mussel (Perna canaliculus) in dogs presumptively diagnosed with degenerative joint disease. → · Super Snouts Joint Power Soft Chews: manufacturer product page → -
"Results are uneven across mussel studies"
One trial found no group difference at day 28 and a gain only at day 56, with placebo dogs also improving. A mussel-curcumin-blackcurrant blend did not beat placebo on owner scores or force plate in dogs.
Clinical efficacy and tolerance of an extract of green-lipped mussel (Perna canaliculus) in dogs presumptively diagnosed with degenerative joint disease. → · The efficacy of a nutritional supplement containing green-lipped mussel, curcumin and blackcurrant leaf extract in dogs and cats with osteoarthritis. → -
"Daily support for heart, eyes, skin and brain"
The dog research reviewed here addressed joints only. No applicable dog evidence for heart, eye, skin or brain benefits from this product's ingredients turned up in this search.
-
"Hemp ingredient"
A dog trial of CBD for arthritis pain exists, but the page gives no CBD or other cannabinoid amount, so it can't be matched to this chew. No evidence retrieved here supports hemp's role in the joint claim.
Claims vs Evidence
3 claims assessed. Support depends on the study results, formulation, and population. Matching an ingredient or dose alone does not establish a benefit.
"Helps with discomfort or stiffness in the joints due to normal activity and exercise"
Partial
Green-lipped mussel's osteoarthritis record is partial: some placebo-controlled dog trials beat placebo, others did not, and products and doses differ. The label prints no mussel amount, so no dose comparison is possible. Studies enrolled dogs with arthritis, not dogs with exercise-related stiffness. No exact-product trial was found in this search.
Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel
Randomized, double-blind, three-arm trial (GLM, carprofen, placebo) · ingredient
More GLM than placebo dogs improved on vet-assessed mobility, owner chronic pain index and pain VAS (P=0.031, 0.025, 0.011). GLM was less effective than carprofen. No side effects detected.
Limitations: Abstract only; dose and effect sizes unavailable. Different preparation from this chew.
- Species
- dog
- Participants / condition
- 45 dogs with chronic pain and radiographic osteoarthritis who completed the trial
- Formulation
- Green-lipped mussel preparation (details not reported in abstract)
- Studied amount, not dosing advice
- Not reported in abstract
- Duration
- 8 weeks, assessed at 4-week intervals
- Funding / conflicts
- Not reported in available abstract
Clinical efficacy and tolerance of a green-lipped mussel extract in dogs with degenerative joint disease
Randomized, double-blind, placebo-controlled with open-label extension · ingredient
No group difference at day 28. At day 56, more GLME dogs improved (p=0.018); musculoskeletal scores only marginally better (p=0.053). Both groups improved over baseline. Differences gone by day 112.
Limitations: Abstract only; owner scoring subjective; placebo group also improved; diagnosis presumptive.
- Species
- dog
- Participants / condition
- 81 dogs presumptively diagnosed with mild-to-moderate degenerative joint disease
- Formulation
- Green-lipped mussel extract (GLME)
- Studied amount, not dosing advice
- Not reported in abstract (given daily)
- Duration
- 56 days controlled; 56 more days open-label
- Funding / conflicts
- Not reported in available abstract
Green lipped mussel plus krill oil extracts (EAB-277), Biota orientalis extracts or NSAIDs for dogs with osteoarthritis pain
Prospective, block-randomized, double-blind, placebo-controlled, four-arm trial · different formulation
At 6 weeks, EAB-277 and meloxicam improved peak vertical force and orthopedic scores more than placebo.
Limitations: Combination with krill oil, so effect can't be assigned to mussel alone; excerpt did not include dose.
- Species
- dog
- Participants / condition
- 101 pet dogs with clinical hip osteoarthritis pain
- Formulation
- Green lipped mussel plus krill oil extract (Antinol Rapid, EAB-277)
- Studied amount, not dosing advice
- Not reported in the excerpt reviewed
- Duration
- 6 weeks
- Funding / conflicts
- Funded by Pharmalink International Ltd.; authors state funder was not involved in design, analysis or writing.
Supplement with green-lipped mussel, curcumin and blackcurrant leaf extract in dogs and cats with osteoarthritis
Double-blind, randomised, placebo-controlled crossover trial (dog results only used here) · different formulation
Vet score (COAST) improved versus baseline but not versus placebo. No differences on owner pain index or force plate in dogs.
Limitations: Mixed blend; small sample; non-responders noted; authors call for larger, longer studies.
- Species
- dog
- Participants / condition
- 32 client-owned dogs with mild to moderate osteoarthritis (cats excluded from this row)
- Formulation
- Liquid blend: green-lipped mussel, curcumin, blackcurrant leaf extract, vitamins C and D3
- Studied amount, not dosing advice
- Weight-based volume: 3 ml (<10 kg) to 10 ml (>45 kg) per day
- Duration
- 16 weeks per period in dogs, 2-week washout
- Funding / conflicts
- Supplement and placebo provided by Synofit Europe B.V.; other funding not reported in the excerpt.
"Can be used as a daily supplement to promote overall wellness for joints, heart, eyes, skin, and brain"
Stretch
Joint evidence for mussel is partial. No applicable dog evidence for heart, eye, skin or brain effects of these ingredients was retrieved, so the whole-body claim goes well beyond the joint research.
Source: Systematic review of the management of canine osteoarthritis. →
Systematic review of the management of canine osteoarthritis
Systematic review of 68 peer-reviewed papers (1985 to July 2007) · ingredient
Moderate level of comfort for a green-lipped mussel functional food modifying structures involved in osteoarthritis. Concerned joint outcomes only.
Limitations: Abstract only; literature up to July 2007; a food, not a chew; no non-joint outcomes.
- Species
- dog
- Participants / condition
- Dogs with osteoarthritis across reviewed trials
- Formulation
- Includes a functional food containing green-lipped mussel
- Studied amount, not dosing advice
- Not reported in abstract
- Duration
- Varied by included trial; not reported in abstract
- Funding / conflicts
- Not reported in available abstract
"Green Lipped Mussel omega-3 fatty acids and glycosaminoglycans support joint mobility"
Partial
Dog trials of mussel products report better mobility or gait measures in some cases, with uneven results. The sources reviewed did not verify glycosaminoglycan content or isolate omega-3 or glycosaminoglycans as the active part. The label gives no amounts.
Effect of a diet enriched with green-lipped mussel on pain behavior and functioning in dogs with clinical osteoarthritis
Controlled clinical trial, sequential control then GLM diet (no placebo group) · ingredient
Peak vertical force improved on GLM diet (P=0.003) with higher plasma omega-3; owner score and activity improved from day 0 to 90. Authors note the control diet may also have helped.
Limitations: No placebo arm; abstract only; diet, not a chew.
- Species
- dog
- Participants / condition
- 23 client-owned dogs with osteoarthritis
- Formulation
- Balanced diet enriched with green-lipped mussel
- Studied amount, not dosing advice
- Not reported in abstract
- Duration
- 30 days control diet, then 60 days GLM diet
- Funding / conflicts
- Not reported in available abstract
Pilot study of a green-lipped mussel nutraceutical in working farm dogs using accelerometry
Double-blind, placebo-controlled crossover pilot · ingredient
Daytime 90th percentile activity higher on the 220 mg product versus placebo (p=0.03); 75th percentile unaffected. Other effects were small or order-dependent.
Limitations: Pilot; diet and activity not controlled; not confirmed osteoarthritis; abstract only.
- Species
- dog
- Participants / condition
- 32 New Zealand working farm dogs with signs of musculoskeletal abnormalities (27 analysed)
- Formulation
- Full-fat green-lipped mussel extract
- Studied amount, not dosing advice
- 180 mg or 220 mg per day
- Duration
- 8 weeks per treatment, 4-week washout
- Funding / conflicts
- Not reported in available abstract
Signals
- The page prints no per-chew amount of green-lipped mussel or hemp, so studied amounts can't be compared [label].
- 'Always non-detectable THC' is stated, but no test report or certificate appears in the reviewed page [label].
- 'Never any fillers, artificial additives, or preservatives' can't be checked because the crawled page shows no full ingredient list [label].
- The '4.6 stars from 156 reviews' rating is a manufacturer-displayed score, not clinical evidence. The star breakdown shows 0 reviews for the 4-, 3-, 2- and 1-star buckets and gives no 5-star count [label].
- The page names its two ingredients, green-lipped mussel and hemp, and lists pack size and weight-band options [label].
Evidence checks
Species and formulation relevance
Dog trials exist for green-lipped mussel in diets, extracts and blends, but none matched this soft chew; no exact-product trial was found in this search. The page also markets the chew to cats, and cat data were not used. Hemp has no matched dog data because no cannabinoid amount is printed [label, pmid18955269, pmid32345916].
Label transparency
The reviewed page names green-lipped mussel and hemp but gives no mussel or hemp amounts, no dosing table and no cannabinoid content. Claims like 'highest quality' and 'non-detectable THC' are manufacturer statements [label].
Independent quality testing
No third-party test report, certificate or quality seal was shown in the reviewed page, and no quality-standard source was supplied. Independent verification is unknown from this material [label].
Study quality and funding
Most mussel studies were small and several were abstract-only. Where funding was reported, it came from companies: Pharmalink International (pmid39450405) and Synofit Europe, which supplied the product and placebo (pmid35274496). Funding was not reported in several abstracts. Results were mixed [pmid16751841, pmid35274496].
Sources (9)
- 1. Super Snouts Joint Power Soft Chews: manufacturer product page →
Manufacturer · Accessed 2026-11-13
- 2. Clinical efficacy and tolerance of an extract of green-lipped mussel (Perna canaliculus) in dogs presumptively diagnosed with degenerative joint disease. →
Study · Accessed 2026-11-13
- 3. Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus). →
Study · Accessed 2026-11-13
- 4. Systematic review of the management of canine osteoarthritis. →
Research review · Accessed 2026-11-13
- 5. Effect of a diet enriched with green-lipped mussel on pain behavior and functioning in dogs with clinical osteoarthritis. →
Study · Accessed 2026-11-13
- 6. The efficacy of a nutritional supplement containing green-lipped mussel, curcumin and blackcurrant leaf extract in dogs and cats with osteoarthritis. →
Study · Accessed 2026-11-13
- 7. A pilot study to detect the effects of a green-lipped mussel (<i>Perna canaliculus</i>) nutraceutical on working farm dogs with musculoskeletal abnormalities using accelerometry. →
Study · Accessed 2026-11-13
- 8. Evaluation of the comparative efficacy of green lipped mussel plus krill oil extracts (EAB-277), <i>Biota orientalis</i> extracts or NSAIDs for the treatment of dogs with osteoarthritis associated pain: a blinded, placebo-controlled study. →
Study · Accessed 2026-11-13
- 9. A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain. →
Study · Accessed 2026-11-10
How this report was produced
AI-assisted evidence analysis. We reviewed published material, not physical products.
Automated source and evidence checks completed on 2026-11-13. These checks are not veterinary review.
Research scope and outstanding checks
Searched Europe PMC-style queries for dog osteoarthritis nutraceutical systematic reviews, the product name with dog terms, and hemp with osteoarthritis in dogs; this is not an exhaustive search. Most studies were abstract-only or partial text. Excluded as not applicable to dog efficacy: cat results (pmid35274496 cat arm, pmid40968477), parrot pharmacokinetics (pmid36795552), a CBD owner-survey (pmid41394909), a CBD eye review (pmid39236742). Hemp/CBD dog papers were not used to grade the product, since no cannabinoid amount is printed. Label images were not tested and no physical testing was done.
Focused research searches:
- (TITLE_ABS:nutraceutical* AND TITLE_ABS:osteoarthrit* AND TITLE_ABS:systematic AND TITLE_ABS:review) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (TITLE_ABS:nutraceutical* AND TITLE_ABS:osteoarthrit* AND TITLE_ABS:systematic AND TITLE_ABS:review) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- (Super AND Snouts AND Joint AND Power) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (Super AND Snouts AND Joint AND Power) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- (TITLE_ABS:Hemp AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (TITLE_ABS:Hemp AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- Per-chew amounts of green-lipped mussel and hemp
- Cannabinoid (CBD) content of the hemp
- Any trial of this exact chew in dogs found in this search
- Third-party test report or quality seal
- Evidence for heart, eye, skin or brain claims
- Verified glycosaminoglycan or omega-3 content